Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
MRVI Maravai LifeSciences
- 5.130
- -0.240-4.47%
Close Dec 23 16:00 ET
- 5.130
- 0.0000.00%
Post 19:49 ET
727.66MMarket Cap-3.07P/E (TTM)
5.420High5.100Low1.58MVolume5.330Open5.370Pre Close8.20MTurnover1.61%Turnover RatioLossP/E (Static)141.84MShares11.55552wk High2.11P/B504.34MFloat Cap4.27552wk Low--Dividend TTM98.31MShs Float63.550Historical High--Div YieldTTM5.96%Amplitude4.275Historical Low5.189Avg Price1Lot Size
Maravai LifeSciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.27%13.14M | -9.17%17.43M | -109.95%-8.47M | -76.45%126.22M | -92.16%7.79M | -87.13%14.17M | -88.32%19.19M | -47.58%85.07M | 45.42%535.98M | 69.10%99.34M |
| Net income from continuing operations | -1,065.11%-175.96M | -21.34%-14.49M | -1,582.49%-22.68M | -128.20%-138.38M | -225.80%-109.98M | -115.15%-15.1M | -107.62%-11.94M | -100.92%-1.35M | 4.56%490.66M | -31.22%87.43M |
| Operating gains losses | ---- | ---- | -318.56%-1.92M | ---- | ---- | ---- | ---- | 322.12%878K | 101.85%208K | --0 |
| Depreciation and amortization | 7.20%14.04M | 23.30%14.55M | 26.09%13.75M | 28.02%48.78M | 29.42%12.98M | 32.16%13.1M | 32.43%11.8M | 17.84%10.91M | 13.59%38.1M | 10.45%10.03M |
| Deferred tax | --0 | --0 | --0 | 1,683.97%754.94M | 10,807.86%764.75M | -159.91%-5.53M | -121.44%-2.76M | -111.50%-1.52M | -9.78%42.32M | -59.86%7.01M |
| Other non cash items | -37.55%1.96M | 88.77%-545K | -47.35%963K | -7,443.03%-671.56M | -14,600.84%-671.68M | 189.30%3.15M | 34.33%-4.85M | 169.65%1.83M | -140.23%-8.9M | 42.35%4.63M |
| Change In working capital | -32.35%5.8M | -87.92%2.24M | -115.57%-10.64M | 317.04%97.84M | 115.09%2.38M | 186.11%8.57M | 266.71%18.55M | 929.58%68.34M | 74.48%-45.08M | 84.30%-15.76M |
| -Change in receivables | 206.41%9.84M | -126.73%-2.02M | -78.30%17.88M | 478.93%84.4M | 65.92%-8.79M | -44.94%3.21M | 6,674.78%7.56M | 3,817.05%82.41M | 68.36%-22.27M | 49.99%-25.77M |
| -Change in inventory | -1.74%-1.52M | -90.26%751K | 124.24%820K | -93.14%649K | -111.33%-2.18M | 35.34%-1.5M | 188.60%7.71M | -381.68%-3.38M | 143.84%9.46M | 251.89%19.27M |
| -Change in prepaid assets | -87.38%439K | -100.93%-199K | 103.17%730K | 115.39%8.14M | 138.64%6.38M | 113.22%3.48M | 269.42%21.29M | -1,014.26%-23.01M | -455.80%-52.87M | -374.63%-16.5M |
| -Change in payables and accrued expense | -155.41%-2.42M | 147.99%7.57M | -215.87%-27.8M | 194.47%20.39M | 185.97%7.81M | -61.93%4.37M | -337.16%-15.77M | 1,235.89%23.99M | 349.01%6.93M | -237.50%-9.08M |
| -Change in other current liabilities | 72.51%-298K | -40.51%-3.73M | 89.38%-1.13M | -176.81%-15.98M | -108.61%-1.64M | -209.38%-1.08M | -241.92%-2.65M | -856.09%-10.6M | 560.12%20.8M | 2,090.80%19.05M |
| -Change in other working capital | -359.57%-244K | -132.51%-132K | -8.70%-1.15M | 103.51%250K | 129.54%808K | -75.77%94K | -76.69%406K | 83.77%-1.06M | 89.50%-7.12M | 95.16%-2.74M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.27%13.14M | -9.17%17.43M | -109.95%-8.47M | -76.45%126.22M | -92.16%7.79M | -87.13%14.17M | -88.32%19.19M | -47.58%85.07M | 45.42%535.98M | 69.10%99.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 42.27%-8.96M | 74.41%-6.18M | 93.91%-4.24M | 54.30%-122.31M | 30.33%-12.9M | -165.44%-15.52M | -1,354.36%-24.16M | 71.14%-69.73M | -353.29%-267.61M | -227.44%-18.52M |
| Net PPE purchase and sale | 48.72%-7.96M | 74.69%-6.18M | -2,752.50%-4.24M | -229.61%-52.69M | -152.55%-12.9M | -139.99%-15.52M | -1,370.50%-24.43M | 105.82%160K | -11.77%-15.99M | 9.67%-5.11M |
| Net business purchase and sale | --0 | --0 | --0 | 70.79%-69.62M | --0 | --0 | --109K | 70.80%-69.73M | -298.70%-238.35M | ---133K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---159K | ---13.28M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 42.27%-8.96M | 74.41%-6.18M | 93.91%-4.24M | 54.30%-122.31M | 30.33%-12.9M | -165.44%-15.52M | -1,354.36%-24.16M | 71.14%-69.73M | -353.29%-267.61M | -227.44%-18.52M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3.32%809K | 100.53%228K | 97.08%-560K | 67.42%-61.09M | 100.71%470K | 102.09%783K | 0.64%-43.13M | 52.60%-19.21M | -17.89%-187.5M | -33.37%-66.12M |
| Net issuance payments of debt | -2.43%-1.52M | -5.75%-1.51M | -10.66%-1.51M | -6.10%-5.77M | -10.44%-1.5M | -9.12%-1.48M | -4.85%-1.43M | 0.00%-1.36M | 9.33%-5.44M | 9.33%-1.36M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | -100.85%-20K | -196.16%-351K | ---- | ---- | ---- | 37.98%2.36M | -3.95%365K |
| Net other financing activities | 96.75%3.81M | 104.16%1.74M | 105.29%945K | 70.01%-55.3M | 103.57%2.32M | 105.26%1.94M | 2.07%-41.71M | 55.25%-17.85M | -19.16%-184.42M | -34.40%-65.13M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3.32%809K | 100.53%228K | 97.08%-560K | 67.42%-61.09M | 100.71%470K | 102.09%783K | 0.64%-43.13M | 52.60%-19.21M | -17.89%-187.5M | -33.37%-66.12M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.21%573.17M | -10.60%561.69M | -9.04%574.96M | 14.67%632.14M | -6.13%579.61M | 5.36%580.18M | 45.61%628.27M | 14.67%632.14M | 133.41%551.27M | 12.69%617.45M |
| Current changes in cash | 973.20%4.99M | 123.87%11.48M | -243.36%-13.27M | -170.70%-57.18M | -131.60%-4.64M | -100.86%-571K | -140.35%-48.1M | 96.77%-3.87M | -74.34%80.87M | 318.93%14.69M |
| Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| End cash Position | -0.25%578.16M | -1.21%573.17M | -10.60%561.69M | -9.04%574.96M | -9.04%574.96M | -6.13%579.61M | 5.36%580.18M | 45.61%628.27M | 14.67%632.14M | 14.67%632.14M |
| Free cash flow | 313.43%3.55M | 234.37%7.88M | -118.30%-14.13M | -88.31%60.67M | -109.67%-9.01M | -101.60%-1.66M | -103.61%-5.87M | -51.61%77.21M | 46.69%518.89M | 75.41%93.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.